STAB

Statera BioPharma Inc
0.0911
0.00 (0.00%)

Statera Biopharma Inc. (STAB) Fundamentals

Statera BioPharma Inc is a pre-clinical and clinical biopharmaceutical company developing multiple product candidates to address unmet medical needs for use in diseases involving immune system dysfunction.
SHARE INFORMATION
Market Cap$ 1,530,533
Shares Outstanding54,661,890
Float47,083,559
Percent Float86.14%
Short Interest774,535.00
Short Percent Float1.4%
Short Interest Ratio0.39
Short Interest Date2022-12-30
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ -2.97
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions56
Institutional Holdings Date2022-12-31
Institutional Bought Previous 3 Months190,967
Institutional Holdings Percent6.8%
Institutional Sold Previous 3 Months538,755
Insider Holdings Date2022-12-31
Insider Bought Previous 3 Months-
Insider Holdings Percent1.7
Insider Sold Previous 3 Months-
Insider Shares Owned905,023
TRADING INFO
52 Week High$ 1.50
52 Week Low$ 0.03
52 Week High Change$ -97.91
21 Day Moving Average$ 0.0611
21 Day Extended Moving Average$ 0.055534
50 Day Moving Average$ 0.0901
50 Day Extended Moving Average$ 0.084726
200 Day Moving Average$ 0.182767
200 Day Extended Moving Average$ 0.425622
10 Day Average Volume1,693,982
20 Day Average Volume2,091,722
30 Day Average Volume1,992,491
50 Day Average Volume2,241,683
Alpha0.035010
Beta1.0880
Standard Deviation0.827769
R20.005024
7 Day Price Change$ 0.0026
7 Day Percent Change10.24%
21 Day Price Change$ -0.062
21 Day Percent Change-68.89%
30 Day Price Change$ -0.0623
30 Day Percent Change-68.99%
Month to Date Price Change$ -0.0532
Month to Date Percent Change-65.52%
Quarter to Date Price Change$ -0.0532
Quarter to Date Percent Change-65.52%
180 Day Price Change$ -0.179
180 Day Percent Change-86.47%
200 Day Price Change$ -0.252
200 Day Percent Change-90.0%
Year to Date Price Change$ -0.0532
Year to Date Percent Change-65.52%

Statera Biopharma Inc. (STAB) Key Ratios

PROFITABILITY
EBIT Margin-10,709.6%
EBITDA Margin-10,649.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin51.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book-0.10
Total Debt To Equity0.20
Int Coverage-24.60
Current Ratio0.10
Leverage Ratio-2.00
Quick Ratio0.00
Long Term Debt To Capital0.16
VALUATION MEASURES
PE Ratio0.00
Enterprise Value$ 8,430,691
Price to Sales0.00
Price to Free Cash-0.30
PE High Last 5 Years-1.60
Price To Book0.20
Price To Cash Flow0.00
PE Low Last 5 Years-5.60
Price to Tangible Book-0.10
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-191.72
Return on Equity-349.50
Return on Capital-208.66

Statera Biopharma Inc. (STAB) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorB F Borgers CPA PC
CEOMichael K. Handley
Emplyoees16
Last AuditUE
CIK0001318641
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address4333 Corbett Drive
Suite 1082
Fort Collins, CO 80525
Websitehttps://www.staterabiopharma.com
Facsimile-
Telephone+1 888 613-8802
Email-


Your Recent History
NASDAQ
STAB
Statera Bi..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.